Global Health

A Fireside Chat....

Posted by ecreese on March 13, 2008 at 10:02am EDT

....without the fire. But that’s okay since it was in the upper 50s yesterday! A Fireside Chat with Cheryl Scott, chief operating officer for the Bill & Melinda Gates Foundation – what a nice way to end a very productive and informative two days in Reston. And what a pleasant, down-to-earth, and passionate woman who has dedicated so much of her life to global health. Once again, the issue of delivery came up and just how vitally important it is.

On Innovation

Posted by ecreese on March 13, 2008 at 9:09am EDT

The afternoon sessions here at PGH really got me thinking about innovation. It’s a word you hear thrown around a lot in biotech – as well as many other areas of science and technology. Actually, it probably gets overused. But when you really think about the word’s true meaning, you realize that innovation is what is required to tackle global health. And that more than one type of innovation is required.

Many people would first think of the innovative scientists it takes to develop a drug or technology to address a neglected disease.

From Bench to Bedside: How Do We Make a Difference?

Posted by ecreese on March 13, 2008 at 9:00am EDT

“Addressing Global Health from Bench to Beside: Necessary Actions at Each State of the Value Chain” was the topic of today’s luncheon discussion. It was another high-level panel discussion with folks from industry, government and the nonprofit sectors. Two issues in particular that kept resurfacing. One was that the term “bedside” is means much more than hospitals. Today, an estimated 2.5 billion people in the world live on less than $2 day.

The Forgotten People

Posted by ecreese on March 11, 2008 at 3:42pm EDT

Every once in a while someone makes a statement that really resonates with you. At today’s luncheon, the topic was global health (of course!) and the challenges and opportunities for engaging in global health product development. Panelists included BIO’s Chairman of the Board,  Joshua Boger, president and CEO of Vertex Pharmaceuticals; Una Ryan, CEO of AVANT Immunotherapeutics; Vijay Samant, president and CEO of Vical; and Henri Termeer, president and CEO of Genzyme Corporation.

It’s All About the E

Posted by ecreese on March 11, 2008 at 11:27am EDT

The question is what does the “e” stand for?

That was the subject of much discussion at the PGH Forum on this overcast morning in Reston, VA.

Syndicate content